Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/182523
COMPARTIR / EXPORTAR:
logo share SHARE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid

AutorSánchez, Ricardo; Ayala, Rosa; Alonso, Rafael Alberto; Martínez, María Pilar; Ribera, Jordi; García, Olga CSIC ORCID; Sánchez-Pina, José María; Mercadal, Santiago; Montesinos, Pau; Martino, Rodrigo; Barba, Pere; González-Campos, José A. CSIC ORCID; Barrios, Manuel; Lavilla, Esperanza; Gil, Cristina; Escoda, Lourdes; Abella, Eugènia; Amigo, M. Luz; Moreno, M. José; Bravo, Pilar; Guàrdia, Ramón; Hernández, Jesús M. CSIC ORCID ; García-Guiñón, Antoni; Piernas, Sonia; Ribera, Josep-Maria; Martínez-López, Joaquín
Palabras claveNeoplasia
Acute lymphoblastic leukemia relapse
Central nervous system
Mutation analysis
BCR-ABL1
Fecha de publicaciónjul-2017
EditorSpringer Nature
CitaciónAnnals of Hematology 96(7): 1069-1075 (2017)
ResumenWe investigated the frequency, predictors, and evolution of acute lymphoblastic leukemia (ALL) in patients with CNS relapse and introduced a novel method for studying BCR-ABL1 protein variants in cDNA from bone marrow (BM) and cerebrospinal fluid (CSF) blast cells. A total of 128 patients were analyzed in two PETHEMA clinical trials. All achieved complete remission after imatinib treatment. Of these, 30 (23%) experienced a relapse after achieving complete remission, and 13 (10%) had an isolated CNS relapse or combined CNS and BM relapses. We compared the characteristics of patients with and without CNS relapse and further analyzed CSF and BM samples from two of the 13 patients with CNS relapse. In both patients, classical sequencing analysis of the kinase domain of BCR-ABL1 from the cDNA of CSF blasts revealed the pathogenic variant p.L387M. We also performed ultra-deep next-generation sequencing (NGS) in three samples from one of the relapsed patients. We did not find the mutation in the BM sample, but we did find it in CSF blasts with 45% of reads at the time of relapse. These data demonstrate the feasibility of detecting BCR-ABL1 mutations in CSF blasts by NGS and highlight the importance of monitoring clonal evolution over time.
Versión del editorhttps://doi.org/10.1007/s00277-017-3002-1
URIhttp://hdl.handle.net/10261/182523
ISSN0939-5555
E-ISSN1432-0584
ISMN10.1007/s00277-017-3002-1
Aparece en las colecciones: (IBIS) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
Sanchez2017_Article_ClinicalCharacteristicsOfPatie.pdf660,31 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

Page view(s)

269
checked on 18-mar-2024

Download(s)

112
checked on 18-mar-2024

Google ScholarTM

Check


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.